Minimal aging model for intervention strategy
exploratoryresearch program · high · Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Explain cross-species aging regimes and organize intervention strategies for extending human healthspan and lifespan.
Minimal physics-informed framework using three macroscopic variables: leading stress response, cumulative entropic damage, and regulatory noise strength.
bioRxiv preprint posted in 2025 proposing the model and intervention roadmap.
The model reproduced survival curves and methylation dynamics across taxa and grouped interventions into modulating stress responses, reducing noise, and slowing entropic damage.
LinAge2 epigenetic and clinical aging clock
exploratorybiomarker · high · Wed Jan 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Provide actionable insights and benchmarking with aging clocks, including mortality prediction and guidance for personalized longevity interventions.
Evaluation and enhancement of clinical and epigenetic clocks, emphasizing clocks trained on survival and functional aging rather than chronological age.
Published in npj Aging in 2025 as an enhanced clinical clock with improved mortality prediction and actionable insights.
Survival- and functional-aging-trained clocks outperformed chronological-age-trained clocks for mortality prediction; the enhanced clinical clock predicted mortality more accurately and aimed to guide personalized interventions.
Biomarkers of aging translation and validation
exploratoryresearch program · medium · Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Advance clinical translation of biomarkers of aging for geroscience, healthy longevity, and evaluation of interventions.
Expert survey, review, and validation framework for omic and other biomarkers of aging, focused on predictive validity, clinical actionability, affordability, individual responsiveness, comparability, and generalizability.
Nature Medicine validation review published in 2024 and Nature Aging recommendations paper published in 2024.
Identified barriers and recommendations for translating biomarkers of aging, including linking biomarkers to clinically actionable insights and validating robust individual-level responsiveness.
Chugai aging antibody drug co-development program
undiscloseddrug program · medium
Co-develop novel antibody drugs for aging.
Strategic pharmaceutical partnership with Chugai Pharmaceutical for antibody drug development.
2025 strategic partnership reported at $250M with Chugai Pharmaceutical.
Chugai antibody aging therapeutics collaboration
undiscloseddrug program · medium
Co-develop novel antibody drugs for aging-related therapeutic targets.
Strategic pharmaceutical collaboration with Chugai Pharmaceutical focused on antibody drug co-development.
2025 strategic partnership with Chugai Pharmaceutical reported at $250M.
In-house anti-aging interventions program
preclinicaldrug program · medium
Advance internal interventions intended to target aging biology and extend healthy lifespan.
Preclinical therapeutic program supported by Gero's AI and aging-physics platform; team includes a Preclinical Program Lead.
Company states it is advancing in-house anti-aging interventions; team page lists Olga Burmistrova PhD as Preclinical Program Lead.
LinAge2 aging biomarker clock
exploratorybiomarker · high
Provide actionable mortality and aging-risk insights for guiding personalized longevity interventions.
Clinical and epigenetic clock benchmarking, including an enhanced clinical clock trained to predict mortality rather than chronological age.
2025 npj Aging publication reported LinAge2 benchmarking and actionable aging-clock insights.
Clocks trained on survival and functional aging outperformed clocks trained on chronological age; the enhanced clinical clock predicted mortality more accurately and provided actionable intervention insights.
LinAge2 aging clock
exploratorybiomarker · high
Provide actionable insights and benchmarking for aging interventions using clinical and epigenetic clocks, with emphasis on mortality prediction.
Evaluation and enhancement of clinical and epigenetic clocks; survival- and functional-aging-trained clocks are compared against chronological-age-trained clocks.
2025 npj Aging publication presenting an enhanced clinical clock for mortality prediction and actionable insights.
The publication reports that clocks trained on survival and functional aging outperform clocks trained on chronological age for mortality prediction.
Minimal aging model intervention framework
exploratoryresearch program · high
Explain aging regimes across species and guide strategies for extending healthspan and lifespan.
Minimal physics-style model using three macroscopic variables: leading stress response, cumulative entropic damage, and regulatory noise strength.
2025 bioRxiv preprint describing intervention strategies organized around stress responses, noise reduction, and slowing entropic damage.
The model is reported to reproduce survival curves and methylation dynamics across taxa and distinguish unstable-species versus stable-species aging regimes.
Minimal model of aging regimes
exploratoryresearch program · high
Explain species-level aging regimes and guide intervention strategies for extending human healthspan and lifespan.
Physics-style minimal model using leading stress response, cumulative entropic damage, and regulatory noise strength to model mortality and biomarker dynamics.
2025 bioRxiv preprint proposed a framework organizing intervention strategies into stress-response modulation, noise reduction, and slowing entropic damage.
The model reproduced survival curves and methylation dynamics across taxa and predicted distinct aging regimes in unstable species versus stable species such as humans.
Physics-informed AI aging therapeutics platform
undisclosedplatform · high
Discover and develop therapeutics targeting the root physics of aging by distinguishing irreversible aging processes from reversible disease processes.
Platform trained on more than 100M longitudinal medical records using physics-informed AI models and real-world medical data.
Platform described publicly as supporting pharmaceutical collaborations and in-house anti-aging interventions.
Physics-informed AI therapeutics platform
undisclosedplatform · high
Identify and develop therapeutics targeting the root physics of aging, with the goal of restoring resilience and delaying age-related disease.
AI platform trained on more than 100M longitudinal medical records using physics-informed models grounded in thermodynamics; used for in-house anti-aging intervention discovery and pharmaceutical collaborations.
Company site describes the platform as active and being used for collaborations and internal therapeutic development.
